Suppr超能文献

表现为锁骨上淋巴结转移而无肾原发性病变的乳头状肾细胞癌。

Papillary Renal Cell Carcinoma Presented With Supraclavicular Lymph Node Metastasis Without Renal Primary Lesion.

作者信息

Thamcharoen Natanong, Chaiwiriyawong Worawit

机构信息

Chulabhorn Hospital, Bangkok, Thailand.

出版信息

World J Oncol. 2013 Feb;4(1):50-53. doi: 10.4021/wjon593w. Epub 2013 Mar 6.

Abstract

Renal cell carcinoma is a rare cancer in Thailand. Most of the patients present in advanced metastatic stage with identifiable renal mass. In this case report, we presents a case of male patient who manifested with supraclavicular lymph node enlargement and CT scan of chest and abdomen showed multiple sites lymph node metastasis but there was no primary mass detected anywhere. The pathology of supraclavicular lymph node was papillary cell adenocarcinoma. The differential diagnoses were papillary thyroid cancer, gastrointestinal tract carcinoma such as pancreato-biliary cancer, non small cell lung cancer, and renal cancer. Immunohistochemistry result were negative for TTF-1, Thyroglobulin, CD7 and CD20 which ruled out non-small cell lung adenocarcinoma, thyroid cancer and gastrointestinal tract cancer respectively. CD10, Vimentin and RCC were all positive and all are specific for renal cell carcinoma. The diagnosis was renal cell carcinoma, papillary cell type. Sunitinib, a tyrosine kinase inhibitor, is the treatment of choice for renal cell carcinoma since it improves objective response rate and shows longer progression free survival than IFNα.

摘要

肾细胞癌在泰国是一种罕见的癌症。大多数患者在出现可识别的肾脏肿块时已处于晚期转移阶段。在本病例报告中,我们呈现了一例男性患者,其表现为锁骨上淋巴结肿大,胸部和腹部的CT扫描显示多处淋巴结转移,但未在任何部位检测到原发肿块。锁骨上淋巴结的病理检查为乳头状细胞腺癌。鉴别诊断包括甲状腺乳头状癌、胃肠道癌(如胰胆管癌)、非小细胞肺癌和肾癌。免疫组化结果显示TTF-1、甲状腺球蛋白、CD7和CD20均为阴性,分别排除了非小细胞肺腺癌、甲状腺癌和胃肠道癌。CD10、波形蛋白和RCC均为阳性,且均为肾细胞癌的特异性指标。诊断为肾细胞癌,乳头状细胞型。舒尼替尼是一种酪氨酸激酶抑制剂,是肾细胞癌的首选治疗药物,因为它能提高客观缓解率,且与干扰素α相比,无进展生存期更长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4b0/5649919/2affd99b2b70/wjon-04-050-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验